Search research articles
Contact Us
Filters
Showing results (31-40 of 89) with videos related to
Page
of 9
Sort By:
Therapie
|
October 1, 2014
[Cetuximab cutaneous adverse drug reactions: a marker of efficacy for metastatic colorectal cancer and head-neck cancer?]
Marlène Soussan-Dahan, Maryse Lapeyre-Mestre, Emmanuelle Bondon-Guitton, et al.
Plos One
|
November 23, 2013
Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study)
Marc Labrunée, Fabien Despas, Philippe Marque, et al.
Therapie
|
July 10, 2016
[Not Available]
Jordan Birebent, Julie Dupouy, Michel Bismuth, et al.
Acute Cardiac Care
|
November 26, 2009
Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording
Fabien Despas, Charlotte Trouillet, Nicolas Franchitto, et al.
Pharmacoepidemiology and Drug Safety
|
February 16, 2017
Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database
Aurore Palmaro, Marie-Eve Rougé-Bugat, Martin Gauthier, et al.
Therapie
|
November 4, 2018
What is pharmacoepidemiology? Definition, methods, interest and clinical applications
Jean-Louis Montastruc, Justine Benevent, François Montastruc, et al.
British Journal of Clinical Pharmacology
|
June 27, 2018
Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase
Julien Mahé, Emilie Patras de Campaigno, Anne-Laure Chené, et al.
Leukemia & Lymphoma
|
May 15, 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas, Maria Chaouki, Sandra de Barros, et al.
Therapie
|
March 3, 2019
The value of a health insurance database to conduct pharmacoepidemiological studies in oncology
Cécile Conte, Charlotte Vaysse, Pauline Bosco, et al.
British Journal of Clinical Pharmacology
|
October 26, 2022
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study
Yoann Zelmat, Cécile Conte, Pernelle Noize, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 89) with videos related to
Sort By:
Page
of 9
Therapie
|
October 1, 2014
[Cetuximab cutaneous adverse drug reactions: a marker of efficacy for metastatic colorectal cancer and head-neck cancer?]
Marlène Soussan-Dahan, Maryse Lapeyre-Mestre, Emmanuelle Bondon-Guitton, et al.
Plos One
|
November 23, 2013
Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study)
Marc Labrunée, Fabien Despas, Philippe Marque, et al.
Therapie
|
July 10, 2016
[Not Available]
Jordan Birebent, Julie Dupouy, Michel Bismuth, et al.
Acute Cardiac Care
|
November 26, 2009
Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording
Fabien Despas, Charlotte Trouillet, Nicolas Franchitto, et al.
Pharmacoepidemiology and Drug Safety
|
February 16, 2017
Real-life practices for preventing venous thromboembolism in multiple myeloma patients: a cohort study from the French health insurance database
Aurore Palmaro, Marie-Eve Rougé-Bugat, Martin Gauthier, et al.
Therapie
|
November 4, 2018
What is pharmacoepidemiology? Definition, methods, interest and clinical applications
Jean-Louis Montastruc, Justine Benevent, François Montastruc, et al.
British Journal of Clinical Pharmacology
|
June 27, 2018
Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase
Julien Mahé, Emilie Patras de Campaigno, Anne-Laure Chené, et al.
Leukemia & Lymphoma
|
May 15, 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas, Maria Chaouki, Sandra de Barros, et al.
Therapie
|
March 3, 2019
The value of a health insurance database to conduct pharmacoepidemiological studies in oncology
Cécile Conte, Charlotte Vaysse, Pauline Bosco, et al.
British Journal of Clinical Pharmacology
|
October 26, 2022
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study
Yoann Zelmat, Cécile Conte, Pernelle Noize, et al.
Page
of 9